Patent application number | Description | Published |
20090186042 | IDENTIFICATION AND USE OF NOVOPEPTIDES FOR THE TREATMENT OF CANCER - Disclosed are compositions relating to novopeptides identified by the presence of frameshift mutations in tumor genes previously not identified as being oncogenic. The disclosed peptides can be used in the disclosed methods for the treatment of cancer. | 07-23-2009 |
20100248977 | Immobilizing an Entity in a Desired Orientation on a Support Material - The present invention relates to the identification and selection of attachment molecules that attach/immobilize an entity having a detectable activity or property on a support in an orientation that provides a detectable activity or property, and to surfaces made of the attachment molecules. | 09-30-2010 |
20110143953 | Synthetic Antibodies - The present invention provides methods for synthetic antibodies, methods for making synthetic antibodies, methods for identifying ligands, and related methods and reagents. | 06-16-2011 |
20120021967 | SYNTHETIC ANTIBODIES - The present invention provides methods for synthetic antibodies, methods for making synthetic antibodies, methods for identifying ligands, and related methods and reagents. | 01-26-2012 |
20120065123 | Synthetic Antibodies - Methods for synthetic antibodies, methods for making synthetic antibodies, methods for identifying ligands, and related methods and reagents. | 03-15-2012 |
20120220540 | SYNBODIES TO AKT1 - The present application provides synbodies against AKT1 differing in amino acid sequence, conjugation chemistry, linker/scaffold, or adjunct moiety. The synbodies are useful for diagnosis and treatment of cancer and as research reagents. | 08-30-2012 |
20130072660 | IDENTIFICATION AND USE OF NOVOPEPTIDES FOR THE TREATMENT OF CANCER - Disclosed are compositions relating to novopeptides identified by the presence of framshift mutations in tumor genes previously not identified as being oncogenic. The disclosed peptides can be used in the disclosed methods for the treatment of cancer. | 03-21-2013 |
20130224730 | PEPTIDE LIGANDS - A method of solid phase selection of peptide ligands for target proteins is presented. 15-20mers or greater are addressed in a microarray, and the target protein and optional competitor bound thereto and binding compared. A specific signal for the target protein indicates that a peptide has strong affinity for the target. Ligands can be coupled to solid supports and used for affinity purification of the target proteins as well as detection and modulation of target proteins. Specific peptide ligands for immuno-purifying norovirus. | 08-29-2013 |
20140128280 | Synthetic Antibodies - The present invention provides methods for synthetic antibodies, methods for making synthetic antibodies, methods for identifying ligands, and related methods and reagents. | 05-08-2014 |
20140221253 | Synthetic Antibodies - Methods for synthetic antibodies, methods for making synthetic antibodies, methods for identifying ligands, and related methods and reagents. | 08-07-2014 |